ArticleFrontiers in oncology2026
Deviations from the inverse relationship between tumor and normal tissue dose and RBE in fast neutron data are compatible with the presence of hypoxia, with possible applications to hypo-fractionated proton therapy.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim of study: Fast neutron data from Hammersmith (UK) showed that the inverse relationship between dose and RBE (Relative Biological Effectiveness) is not maintained in many Methods: A new model uses LQ formulism with radiosensitivity changes increasing with LET and with LET-related reductions in hypoxia. Inequalities are defined for the parameter ratios used to estimate RBEs in oxic and hypoxic compartments, with the overall RBE being also determined by the initial hypoxic fraction and the compartmental surviving fractions with increasing dose. Extrapolation from neutrons to protons is assumed by using a 90% RBE reduction for the excess of RBE beyond unity. Also, the separate influence of the dose rate effect on RBE at higher doses is investigated. Results: For normal skin, the C3H mouse mammary carcinoma and the Ehrlich ascites cancer, three quite different RBE responses are fitted by the model within practical statistical bounds. The overall RBE initially follows the oxic curve but shifts with increasing dose to the higher hypoxic RBE curve, the response depending mostly on the pretreatment hypoxic fraction and other hypoxia parameters. Such patterns of RBE changes are also obtained for protons, but cannot be obtained from the dose rate effect at higher dose, although the DNA repair rate will increase RBE with dose. Conclusions: This tentative but complex radiobiological modelling study shows that the Hammersmith neutron RBE results can be simulated by the presence of two physiological compartments and that similar RBE changes may occur for protons. Further experimental research is suggested for determining if protons do show effects at similar dose ranges, which could be relevant for hypo-fractionated or single fraction schedules.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.